IndustryPRwire -- Global Blood Therapeutics announced that an expanded access protocol (EAP) for Oxbryta® (voxelotor) in pediatric patients with sickle cell disease (SCD) has been initiated and is cu…
IndustryPRwire -- BioSig Technologies announced a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop a next-generation AI- and machine learning-powered sof…
IndustryPRwire - Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval of the DiamondTemp™ Ablation (DTA) system which treats patients with recurrent, symptomatic paro…
IndustryPRwire - Catabasis Pharmaceuticals announced that it has acquired Quellis Biosciences Inc, a privately-held emerging biopharmaceutical company focused on discovering best-in-class new molecul…
IndustryPRwire -- OraSure Technologies announced its OMNIgene®·ORAL (OME-505) saliva collection device, a product of Ottawa-based subsidiary DNA Genotek, has received authorization from Health Canada…
IndustryPRwire -- RedHill Biopharma announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib (Yeliva®, ABC294640), to address prospective d…
